高级搜索
扶正抑癌汤合并化疗治疗晚期肺癌临床观察[J]. 肿瘤防治研究, 1998, 25(3): 211-213.
引用本文: 扶正抑癌汤合并化疗治疗晚期肺癌临床观察[J]. 肿瘤防治研究, 1998, 25(3): 211-213.
Clinical Observation of the Combination of the Chemotherapy and the Support healthy Energy Decoction in the Management of Advanced Lung Cancers[J]. Cancer Research on Prevention and Treatment, 1998, 25(3): 211-213.
Citation: Clinical Observation of the Combination of the Chemotherapy and the Support healthy Energy Decoction in the Management of Advanced Lung Cancers[J]. Cancer Research on Prevention and Treatment, 1998, 25(3): 211-213.

扶正抑癌汤合并化疗治疗晚期肺癌临床观察

Clinical Observation of the Combination of the Chemotherapy and the Support healthy Energy Decoction in the Management of Advanced Lung Cancers

  • 摘要: 本文报道“中药扶正抑瘤汤”并用化疗(简称综合组)治疗晚期肺癌35例同单纯化疗组(简称单化组)30例作了比较,以观察“扶正抑瘤汤”在治疗晚期肺癌的临床作用。全部病例均有病理学依据,Karnofsky(卡氏)评分在60~70分。治疗方法:两组病人均接受化疗至少两个疗程,化疗方案:小细胞肺癌(SCLC)用EP与CMC交替q3W,非小细胞肺癌(NSCLC)用VMP或EMP,每疗程间隔3~4周。综合组加中药扶正抑瘤汤口服。结果:综合组和单化组的有效率(CR+PR)分别为54.28%、30%,统计学有显著差异(P<0.05),综合组主要症状的改善优于单化组,化疗引起的副作用小于单化组。提示扶正抑瘤汤配合化疗可以起到增效减毒作用,提高患者的生活质量和近期疗效。

     

    Abstract: Therapeutic effect of the support healthy energy decoction plus chemotherapy(group A) and chemotherapy only (group B)in the treatment of advanced lung cancerswas compared. Methods: Comparsion of 65 advancde lung cancers was carried out,group A-35 cases and group B-30 cases. The clinical and pathological results werecompared by the X2 test. Results: The group A gave an overall response rate 54.28%,and the group B 30% (P0.05). Meaniwhile, the group A had a better improvement ofthe clinical symptoms and less side toxicities. Conclusion: In advanced lung cancer casesas treated with combination of chemotherapy and the support healthy energy decoction,clinical results were more satisfied than those of group B.

     

/

返回文章
返回